share_log

Recap: Aptose Biosciences Q4 Earnings

Recap: Aptose Biosciences Q4 Earnings

回顧:Aptose Biosciences第四季度收益
Benzinga ·  03/26 16:10

Aptose Biosciences (NASDAQ:APTO) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:02 PM.

Aptose Biosciences(納斯達克股票代碼:APTO)於2024年3月26日星期二下午4點02分公佈了其第四季度業績。

Here's what investors need to know about the announcement.

以下是投資者需要了解的有關該公告的信息。

Earnings

收益

Aptose Biosciences beat estimated earnings by 9.0%, reporting an EPS of $-1.44 versus an estimate of $-1.59.

Aptose Biosciences的收益比預期高出9.0%,每股收益爲-1.44美元,而估計爲-1.59美元。

Revenue was down $0 from the same period last year.

收入比去年同期下降了0美元。

Past Earnings Performance

過去的收益表現

Last quarter the company beat on EPS by $0.29 which was followed by a 24.0% drop in the share price the next day.

上個季度,該公司的每股收益高出0.29美元,隨後第二天股價下跌了24.0%。

To track all earnings releases for Aptose Biosciences visit their earnings calendar here.

要追蹤Aptose Biosciences的所有業績,請在此處訪問其業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閱。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論